Innovita Biological Technology Co., Ltd.

27
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005Q14
CNY
56.40
2.71 (5.05%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
418.00
617.00
475.00
438.00
326.00
1,037.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
418.00
617.00
475.00
438.00
326.00
1,037.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
105.00
0.00
0.00
95.00
63.00
100.00
Operating Expenses
0.00
0.00
0.00
0.00
0.00
0.00
General and Administration Expenses
88.00
148.00
95.00
84.00
73.00
148.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
283.00
378.00
271.00
338.00
188.00
319.00
Operating Profit (PBDIT) excl Other Income
134.00
239.00
204.00
100.00
138.00
717.00
Other Income
28.00
36.00
33.00
69.00
5.00
-29.00
Operating Profit (PBDIT)
193.00
300.00
243.00
189.00
156.00
681.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
36.00
29.00
32.00
25.00
19.00
6.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
163.00
277.00
199.00
165.00
137.00
674.00
Provision for Tax
15.00
29.00
24.00
13.00
17.00
102.00
Profit After Tax
144.00
246.00
173.00
150.00
120.00
571.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
1.07
1.81
1.28
1.11
0.88
4.20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -32.29% vs 29.80% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -43.94% vs 17.24% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 26.11% vs -17.19% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is -41.48% vs 41.92% in Dec 2024

Compare Profit and Loss Results of Innovita Biological Technology Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
418.00
0
418.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
418.00
0
418.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
105.00
0
105.00
0%
Operating Expenses
0.00
0
0.00
0%
General and Administration Expenses
88.00
0
88.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
283.00
0
283.00
0%
Operating Profit (PBDIT) excl Other Income
134.00
0.00
134.00
0%
Other Income
28.00
0
28.00
0%
Operating Profit (PBDIT)
193.00
0
193.00
0%
Interest
0.00
0
0.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
36.00
0
36.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
163.00
0
163.00
0%
Provision for Tax
15.00
0
15.00
0%
Profit After Tax
144.00
0
144.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.0712
0
1.07
0%
Profit And Loss - Net Sales
Net Sales 418.34 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -32.29% vs 29.80% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 134.37 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -43.94% vs 17.24% in Dec 2024

Profit And Loss - Interest
Interest 0.26 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 26.11% vs -17.19% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 144.47 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -41.48% vs 41.92% in Dec 2024